ask="26.00"
ask_size="4000"
average_daily_volume="698920"
bid="2.31"
bid_size="400"
book_value="0.32"
change="+0.07"
change_from_200_day_moving_average="0.82"
change_from_50_day_moving_average="0.26"
change_from_52_week_high="-0.12"
change_From_52_week_low="1.66"
change_in_percent="+3.10%"
close="2.33"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.17"
ebitda="-24.62M"
eps_estimate_current_year="-0.17"
eps_estimate_next_quarter="-0.04"
eps_estimate_next_year="-0.10"
ex_dividend_date="N/A"
float_shares="116418000"
high="2.36"
high_52_weeks="2.45"
last_trade_date="12/30/2016"
last_trade_price="2.33"
last_trade_size="9409"
last_trade_time="4:00pm"
low="2.24"
low_52_weeks="0.67"
market_capitalization="361.35M"
moving_average_200_day="1.51"
moving_average_50_day="2.07"
name="Antares Pharma
Inc."
notes="N/A"
one_year_target_price="3.63"
open="2.31"
pe_ratio="N/A"
peg_ratio="-0.17"
percent_change_from_200_day_moving_average="+54.04%"
percent_change_from_50_day_moving_average="+12.37%"
percent_change_from_52_week_high="-4.90%"
percent_change_from_52_week_low="+247.76%"
previous_close="2.26"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.15"
price_per_sales="7.03"
revenue="49.83M"
shares_outstanding="155086000"
short_ratio="5.02"
stock_exchange="NCM"
symbol="ATRS"
volume="597409"
weeks_range_52="0.67 - 2.45"
